Lipitor Injury Attorneys
Lipitor works by preventing an enzyme in the liver from creating low density lipids (LDLs), or “bad” cholesterol. The drug essentially blocks the production of this cholesterol thereby reducing the user’s cholesterol level and risk of heart disease.
Lipitor has been dubbed “the world’s all-time biggest selling prescription medication,” with more than $130 billion in total sales for its manufacturer, Pfizer Inc. It belongs to a class of cholesterol-lowering drugs, called “statins,” that are taken by roughly 21 million Americans.
The findings of recent studies have sparked the FDA to issue a drug safety communication in February 2012 regarding important safety label changes mandated for Lipitor and other statins. As part of the FDA announcement, the agency also included warnings to the public regarding the risks of serious side effects – including type 2 diabetes – when using Lipitor.
In February of 2012, the U.S. Food and Drug Administration (FDA) labeling change indicates that statins, including Lipitor (atorvastatin calcium), may increase a woman’s risk of developing Type 2 diabetes. This diabetes risk may be especially high among postmenopausal middle-aged and older women, research shows.
FDA Warning
http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm
For a free legal consultation with a Lipitor Diabetes lawyer serving Dallas, call 877-239-4878
The University of Massachusetts’ study, published in January 2012, focused on nearly 154,000 women. By the end of the study, researchers found that more than 10,200 women in the study had developed new cases of type 2 diabetes and that those with a body mass index (BMI) that was less than 25 had a greater risk of developing the disease. After accounting for the participating subjects’ age, weight, lifestyle and other factors that may contribute to the development of diabetes, researchers found that postmenopausal women taking statins like Lipitor had up to a 46 percent increased risk of developing type 2 diabetes.
Study Results
http://archinte.jamanetwork.com/article.aspx?articleid=1108676
Lipitor works by preventing an enzyme in the liver from creating low density lipids (LDLs), or “bad” cholesterol. The drug essentially blocks the production of this cholesterol thereby reducing the user’s cholesterol level and risk of heart disease.
Lipitor has been dubbed “the world’s all-time biggest selling prescription medication,” with more than $130 billion in total sales for its manufacturer, Pfizer Inc. It belongs to a class of cholesterol-lowering drugs, called “statins,” that are taken by roughly 21 million Americans.
Dallas Lipitor Diabetes Lawyer Near Me 877-239-4878
The findings of recent studies have sparked the FDA to issue a drug safety communication in February 2012 regarding important safety label changes mandated for Lipitor and other statins. As part of the FDA announcement, the agency also included warnings to the public regarding the risks of serious side effects – including type 2 diabetes – when using Lipitor.
Contact our Dallas Lipitor Diabetes Attorneys today
In February of 2012, the U.S. Food and Drug Administration (FDA) labeling change indicates that statins, including Lipitor (atorvastatin calcium), may increase a woman’s risk of developing Type 2 diabetes. This diabetes risk may be especially high among postmenopausal middle-aged and older women, research shows.
FDA Warning
http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm
Complete a Free Case Evaluation form now
The University of Massachusetts’ study, published in January 2012, focused on nearly 154,000 women. By the end of the study, researchers found that more than 10,200 women in the study had developed new cases of type 2 diabetes and that those with a body mass index (BMI) that was less than 25 had a greater risk of developing the disease. After accounting for the participating subjects’ age, weight, lifestyle and other factors that may contribute to the development of diabetes, researchers found that postmenopausal women taking statins like Lipitor had up to a 46 percent increased risk of developing type 2 diabetes.
Study Results
http://archinte.jamanetwork.com/article.aspx?articleid=1108676
Call or text 877-239-4878 or complete a Free Case Evaluation form
